Guntramsdorf, Austria

Eckhard Rupprecht

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Kg. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eckhard Rupprecht. Retrieved from https://idiyas.com/inventor/eckhard-rupprecht-300q4way

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Eckhard Rupprecht

Introduction

Eckhard Rupprecht is a notable inventor based in Guntramsdorf, Austria. He has made significant contributions to the field of chemistry, particularly with his work on phenylacetic acid benzylamides. His innovative approach has led to the development of a patent that showcases his expertise and creativity.

Latest Patents

Eckhard Rupprecht holds a patent for phenylacetic acid benzylamides, which have the following general structure. This invention highlights his ability to create compounds that may have various applications in the pharmaceutical industry. The patent demonstrates his commitment to advancing chemical research and development.

Career Highlights

Rupprecht is associated with Boehringer Ingelheim KG, a leading global pharmaceutical company. His role at the company allows him to collaborate with other talented professionals in the field. His work has contributed to the company's reputation for innovation and excellence in drug development.

Collaborations

Eckhard Rupprecht has worked alongside notable colleagues such as Wolfgang Grell and Rudolf Hurnaus. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise. Together, they have contributed to advancements in their respective fields.

Conclusion

Eckhard Rupprecht's contributions to the field of chemistry and his innovative patent for phenylacetic acid benzylamides exemplify his dedication to scientific advancement. His work at Boehringer Ingelheim KG and collaborations with esteemed colleagues further highlight his impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…